Medicinal Genomics Corp.have announced that AOAC International has approved its PathoSEEK® 5-Color Aspergillus Multiplex Assays with SenSATIVAx Extraction for cannabis flower and infused edibles. MGC is the first manufacturer to receive certification for cannabis-infused edibles and is also the first to offer AOAC-approved cannabis assays for two different qPCR machines: Agilent AriaMX and BioRad CFX96.
MGC's certification was awarded on its performance along multiple PTM Program parameters, such as robustness, product consistency, stability, inclusivity, exclusivity, and matrix studies, and most importantly, its ability to quickly and accurately detect the four hazardous Aspergillus species: A. flavus, A. fumigatus, A. niger, and A. terreus in both cannabis flower and cannabis infused edibles.
MGC's PathoSEEK Microbial Safety Testing Platform utilizes a novel, contamination-free, PCR-based assay and provides an internal plant DNA control for every reaction. It involves a simple two-step protocol that is both flexible and automation compatible. The 5-Color Aspergillus Multiplex microbial detection assay uses a multiplexing strategy with an internal plant DNA reaction control to ensure accurate detection of four Aspergillus species, as well as cannabis DNA in just one reaction. Unlike other techniques, this multiplexing strategy verifies the performance of the assay when detecting pathogens, which minimizes false negative results due to reaction set-up errors or failing experimental conditions.
Visit www.medicinalgenomics.com
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.
